Graham Colditz is an internationally known breast cancer prediction expert. Joy Jiang is a young biostatistician. Together they created Prognosia’s cutting edge software.
Graham Colditz is an internationally recognized scientist who’s written more than one thousand research papers and created several award-winning models for predicting women’s breast cancer risk. But it wasn’t until a young biostatistician named Joy Jiang arrived at Washington University in St. Louis that the idea of a startup took hold. The two developed AI technology that analyzes subtle changes in mammograms over time and predicts a woman’s five-year risk for cancer. Then in 2024, Graham and Joy co-founded Prognosia to commercialize their software. A little more than a year later, Prognosia was acquired for an undisclosed price by Lunit, a South Korean company whose AI software helps doctors detect cancer.
Midwest Moxie's executive producer is Audrey Nowakowski. She produced this episode. Subscribe to Midwest Moxie wherever you get your podcasts. And if you love Midwest Moxie as much as we do, help us out by posting a review.
